I have cancer again. Don’t feel sorry for me
For the second time in my adult life, I have cancer. I appreciate the love, support and prayers…
Striking Legacy Health workers in OR, WA reach tentative deal to end walkout
Legacy Health workers on Wednesday said they reached a tentative agreement to end a strike now in its…
Hospital system restricts visitation due to rising flu cases
Due to increased rates of community influenza and other respiratory illnesses, Prisma Health will restrict anyone age 15…
Pittsburgh-based Highmark prepares for the future of healthcare with artificial intelligence
MENU ACCOUNT SECTIONS OTHER CLASSIFIEDS CONTACT US / FAQ
Little-known Texas law could help keep health insurance premiums low when federal subsidies expire in a few days
Texas is one of a few states that have this law, giving residents under the Affordable Healthcare Act…
One young Tassie woman’s battle with OCD
Podcast Intro: Â ABC Listen. Podcasts, radio, news, music and more. Podcast Opener: There’s a lot of hard working…
Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access
This article first appeared on GuruFocus. Weight-loss drugs known as GLP-1s are increasingly reshaping healthcare and the pharmaceutical…
8 Friendly Towns To Retire In California
If happiness is associated with the aesthetic quality of the surrounding landscape, Californians are certainly the happiest folks…
The health care industry expected to see Oregon’s greatest job growth over next decade
Jobs in health care are expected to grow in Oregon over the next decade. On Aug. 27, 2024,…
Children’s Hospital Colorado fighting gender-affirming care subpoena
Children’s Hospital Colorado is fighting the U.S. Department of Justice in court over a demand that the hospital…
Northern Light Health lost $15M in 2025, audit shows
There’s still time to make a gift in 2025 to power BDN reporting for the year ahead. Make…
Johnson & Johnson halts mid-stage trial of experimental eczema drug
Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…